Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺47.514,4, with a 24-hour trading volume of ₺79,91B. The asset's market cap is ₺42,38T, after moving 2.27% in the last day.
Tokenized Eli Lilly And Co is trading at ₺47.583,75, with a tokenized market cap of ₺267,62M and a 24-hour trading volume of ₺97,12M. The tokenized asset has moved 3.43% in the past 24 hours.